Treatments for metabolic diseases
Resalis Therapeutics has raised €20M across 2 funding rounds from 5 investors, most recently a Series A round in Jan 2024. Based in Turin, Italy; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2024-01-04 | Series A | €10M | Angel Investors,Claris Ventures,Sunstone Life Science Ventures | View deal → |
| 2023-02-22 | Seed | €10M | Claris Ventures,Italian Angels for Growth,Pietro Puglisi | View deal → |
